International Biotechnology Trust (LSE:IBT) ROC %: % (As of Feb. 2026)


LSE:IBT International Biotechnology Trust PLC LSE:IBT
32 GF Score
Price £10.50
! 4 Warning Signs
View Full Analysis

What is International Biotechnology Trust ROC %?

International Biotechnology Trust LSE:IBT +1.94% 32 ROC % is % as of Feb. 2026. GuruFocus rates LSE:IBT with a GF Score™ of 32/100. The stock has 4 warning signs investors should review.

ROC %does not apply to banks.

LSE:IBT
32GF Score
International Biotechnology Trust PLC LSE:IBT
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROC % →
What does a ROC % of % mean?
International Biotechnology Trust (LSE:IBT) has a ROC % of % as of Feb. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on International Biotechnology Trust and its competitors.
Is International Biotechnology Trust's ROC % too high?
International Biotechnology Trust's current ROC % is %. Overall, International Biotechnology Trust has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's ROC % compare to VRTX and REGN?
International Biotechnology Trust's ROC % of % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Biotechnology company?
A good ROC % depends on the Biotechnology industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on International Biotechnology Trust and its competitors. International Biotechnology Trust's current ROC % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current ROC % of %. The current ROC % is %. International Biotechnology Trust's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current ROC % is % as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

International Biotechnology Trust Business Description

Address 1 London Wall Place, London, GBR, EC2Y 5AU
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
32GF Score

Get the complete analysis for LSE:IBT

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£10.50
Price